政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/125939
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 113311/144292 (79%)
Visitors : 50938970      Online Users : 963
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version
    政大典藏 > College of Commerce > MBA Program > Theses >  Item 140.119/125939


    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/125939


    Title: 在美國和台灣的健保制度下，製藥業是如何適應新的數位化的改變
    How the Pharmaceutical Industry Adapts to the newly Digital regime? The Comparison Study between Taiwan and the U.S. Healthcare System
    Authors: 楊筑鈞
    Yang, Ju-Jiun
    Contributors: 彭朱如
    黃國峯
    Peng, Tzu-Ju
    Huang, Kuo-Feng
    楊筑鈞
    Yang, Ju-Jiun
    Keywords: 美國
    台灣
    健保制度
    製藥業
    數位化
    改變
    Pharmaceutical
    Adapts
    Digital
    Comparison
    Taiwan
    U.S.
    Date: 2019
    Issue Date: 2019-09-05 17:33:29 (UTC+8)
    Abstract: Abstract
    The healthcare system of the United States can be seen as a complete opposite spectrum compared to the Taiwan healthcare system. Taiwan’s healthcare system focuses on providing medical help at lower costs for the current population at a high-speed rate. Whereas the United
    States is looking at providing medical assist at higher costs with the most current and higher cost medical technology. In this context, what can we define as the biggest difference between the two systems? At the same time, what are the pros and cons of each system?
    In addition, we are also going to look at how new digital innovations has taken each healthcare
    system so far in the current society. What kind of digital innovation techniques has the Taiwan medical system been implementing compared to the United States? Based on a specific case regarding an international pharmaceutical company, we can take a closer look at how exactly new
    digital techniques has taken revolution from the past until now.
    Reference: Reference

    Abutaleb, Yasmeen.(2018), “U.S. healthcare spending to climb 5.3 percent in 2018:
    agency,” Health News, https://www.reuters.com/article/us-usa-healthcare-spending/ushealthcare-
    spending-to-climb-53-percent-in-2018-agency-idUSKCN1FY2ZD

    Ajit, Kumar. Sanjeev, Maskara.(2015), “U.S. versus Taiwan Healthcare System Reforms:
    What Can India Learn from them,” American Journal of Industrial and Business Management,
    Vol.5, 119-144.

    Amadeo, Kimberly.(2019), “The Rising Cost of health Care by Year and Its Causes,” The
    Balance, https://www.thebalance.com/causes-of-rising-healthcare-costs-4064878

    Camillo, Cheryl.(2016), “The U.S. Healthcare System: Complex and Unequal,” Global
    Social Welfare, Vol.3, No.2

    Chakravarty, Sudeep.(2019), “World’s Top 10 Pharmaceutical Companies by Revenue,”
    Market Research Reports,
    https://www.marketresearchreports.com/blog/2019/01/30/world%E2%80%99s-top-10-
    pharmaceutical-companies-revenue

    Cheng, Tsung-Mei.(2019), “Health Care Spending In the US and Taiwan: A Response To
    It’s Still the Prices, Stupid, And A Tribute To Uwe Reinhardt,” Health Affairs Blog,
    https://www.healthaffairs.org/do/10.1377/hblog20190206.305164/full/

    Cohen, Jessica.(2018), “Amazon, Merck, Accenture to launch data-driven drug
    development platform,” Becker’s Hospital Review,
    https://www.beckershospitalreview.com/supply-chain/amazon-merck-accenture-to-launch-datadriven-
    drug-development-platform.html

    Devine, T.(2017), “Merck & Co. is working with Amazon Web Services (AWS) to
    explore the creation and delivery of digital initiatives for people living with chronic disease by using Amazon Lex, the deep learning technologies that power Amazon Alexa. (TECH Talk),” Chain Drug Review, Vol.39, No.9, 53.

    Dirngal, Andreas. Cocoli, Myrvet.(2016), “Global Generic Pharmaceutical Industry
    Review,” CRD-Healthcare, https://www.krungsri.com/bank/getmedia/a5599675-701b-49d8-
    a857-33d247c773a0/BTMU-Research-201602-29.aspx

    Ellis, Monique.(2019), “Top 10 pharmaceutical companies in 2019,” Proclinical,
    https://www.proclinical.com/blogs/2019-3/the-top-10-pharmaceutical-companies-in-the-world-2019

    Frakt, Austin. Carroll, Aaron.(2013), “The Quality Imperative A Commentary on theU.S. Healthcare System,” American Journal of Preventive Medicine, Vol.44, No.1S1, S22-S26.

    Ho, Cai-Wei.(2018), “A Study on the Operation Strategies of Prescription Generic Firms-
    A case study of S Company,”
    http://ntcuir.ntcu.edu.tw/bitstream/987654321/13414/2/NEM105108.pdf

    Kamangar, F. Millsop, JW. Tsai, D.(2015), “What can U.S. dermatology learn from
    health care systems abroad? An observation of Taiwan’s system of clinical efficiency as a
    possible model for increased patient access to care and affordability,” Dermatol Online J,
    Vol.21, No.5

    Kaiser, Henry.(2018), “Key Facts about the Uninsured Population,” KFF,
    https://www.kff.org/uninsured/fact-sheet/key-facts-about-the-uninsured-population/

    Kasi, Adam.(2017), “Porter Five Forces Analysis of US Pharmaceutical Industry,”
    Industries, https://www.porteranalysis.com/porter-five-forces-analysis-of-us-pharmaceuticalindustry/

    Leonard, Kwok-han.(2013), “Drug makers are the midst of a digital revolution:
    pharmaceutical firms are sharpening their focus on multichannel marketing and analytics,” CRM
    Magazine, Vol.17, No.7, 22.

    Madisha, Lusi.(2018), “Difference between Qualitative Analysis and Quantitative
    Anaylsis,” Difference Between.net, http://www.differencebetween.net/science/differencebetween-
    qualitative-analysis-and-quantitative-analysis/

    Manz, Christopher. Ross, Joseph. Grande, David.(2014), “Marketing to Physicians in a
    Digital World,” The New England Journal of Medicine, Vol.371, 1857-1859.

    Membrillo, Alex.(2019), “Healthcare Digital Marketing Trends to Expect in 2019,” Cardinal, https://www.cardinaldigitalmarketing.com/blog/healthcare-digital-marketing-trendsinnovations-
    seo-ppc-2019/

    Merck.(2018), “Redefining Health Care with Digital Innovation,”
    https://www.merck.com/about/featured-stories/austin.html

    Nathan, Jay. Venkatatraman, Ray.(1999), “Management of quality, capacity, and
    productivity at Merck.” Hospital Materiel Management Quarterly, Vol.20, No.3, 64.

    Porter, Michael.(1979), “How Competitive Forces Shape Strategy,” Harvard Business Review, Vol.57, 137-145

    Puhl, N. Woulfe, J. “Healthcare Sector Report.AMP,”
    http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=13208

    Rau, Hsiao-Hsien. Hsu, Chien-Yeh.(2010), “Developing electronic health records in Taiwan,” IT professional, Vol.12, 17-25

    Sands, Rory.(2013), “Porters 5 Forces-Pharmaceutical Industry,”
    https://prezi.com/h5l8wrg2f6rr/porters-5-forces-pharmaceutical-industry/

    Sharma, Ankit.(2018), “Role of Digital Marketing in Healthcare Industry,” AeroLeads,
    https://aeroleads.com/blog/role-digital-marketing-health-care-industry/

    Wang, Guang-Xu.(2012), “A network approach for researching political feasibility of
    healthcare reform: The case of universal healthcare system in Taiwan,” Social Science &
    Medicine, Vol.75, 2337-2344.

    Whiteside, Eric.(2016), “The Industry Handbook: Pharma Industry,” Investopedia,
    https://www.investopedia.com/articles/markets/051316/industry-handbook-pharma-industry.asp
    Description: 碩士
    國立政治大學
    企業管理研究所(MBA學位學程)
    105363126
    Source URI: http://thesis.lib.nccu.edu.tw/record/#G0105363126
    Data Type: thesis
    DOI: 10.6814/NCCU201900824
    Appears in Collections:[MBA Program] Theses

    Files in This Item:

    File SizeFormat
    312601.pdf1886KbAdobe PDF20View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback